Loading chat...

MO HB2922

Bill

Official Source

Status

Introduced

1/12/2026

Primary Sponsor

Jeff Myers

Click for details

Origin

House of Representatives

2026 Regular Session

AI Summary

  • Expands Missouri's "Right to Try" law to cover patients with life-threatening or severely debilitating conditions, not just terminal illnesses
  • Removes the exclusion of Schedule I controlled substances from the definition of investigational drugs, biological products, or devices
  • Requires investigational treatments to have completed phase one clinical trials but not yet received full FDA approval
  • Protects physicians from license revocation for recommending investigational treatments to eligible patients and prohibits action against providers' Medicare certification
  • Shields manufacturers, distributors, prescribers, and administrators from state law liability except in cases of gross negligence or willful misconduct

Legislative Description

Modifies provisions relating to alternative therapies

Last Action

Reported Do Pass (H) - AYES: 12 NOES: 0 PRESENT: 0

3/16/2026

Committee Referrals

Emerging Issues2/23/2026

Full Bill Text

No bill text available